AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8020902
Drug: Ofloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (400 mg/day for 10 days, first intravenously then orally) plus intravenous bolus of amoxicillin plus clavulanic acid (1 g) before each endoscopy
Trial: 8020902
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy only in cases of established or suspected infection
Trial: 29622506
Drug: Polypill (aspirin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypill (aspirin, statin, and two blood pressure lowering drugs)
Trial: 22465565
Drug: Sucrose octaacetate
RxNorm normalized name: Sucrose Octaacetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose octaacetate solution (bitter)
Trial: 16261108
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous morphine (SC)
Trial: 16261108
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural morphine (ED)
Trial: 8826100
Drug: Albendazole 800
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 800 mg with a fatty breakfast for three consecutive days
Trial: 25893651
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) for 10 weeks prior to bariatric surgery
Trial: 21724838
Drug: NNC126‐0083 (0.01,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC126‐0083 (0.01, 0.02, 0.04, or 0.06 mg protein/kg)
Trial: 21724838
Drug: NNC126‐0083 (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC126‐0083 (0.06 mg protein/kg)
Trial: 21724838
Drug: NNC126‐0083 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC126‐0083 (all doses)
Trial: 11846327
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen plus medroxyprogesterone acetate (CCEP) 0.625 mg plus 5 mg daily
Trial: 31609077
Drug: MAS062D lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAS062D lotion
Trial: 31585489
Drug: Hydrophilic cream
RxNorm normalized name: HYDROPHILIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrophilic cream
Trial: 28693622
Drug: Social Recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social Recovery Therapy (SRT) plus optimised treatment as usual (enhanced standard care)
Trial: 1750102
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg base chloroquine once weekly
Trial: 1750102
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg daily proguanil
Trial: 1750102
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg base chloroquine/kg (25 CQ) over three days for treatment of breakthroughs
Trial: 7102531
Drug: Oral pindolol
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pindolol 5 mg
Trial: 7102531
Drug: Oral pindolol
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pindolol 10 mg
Trial: 361333
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol 80 mg
Trial: 7102531
Drug: Intravenous propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propranolol 0.3 mg/kg
Trial: 28727703
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (ITM) 7 µ/kg
Trial: 23077087
Drug: Memantine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine 20 mg/day
Trial: 15071189
Drug: Carbenoxolone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone (100 mg three times per day)
Trial: 11903914
Drug: i.v. erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. erythromycin 2 mg kg‐1 over 20 min
Trial: 11903914
Drug: sublingual isosorbide
RxNorm normalized name: isosorbide dinitrate Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual isosorbide 10 mg
Trial: 18586645
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - Soybean oil capsules
Trial: 6240166
Drug: Topical tetracycline
RxNorm normalized name: TETRACYCLINE HYDROCHLORIDE 30 mg in 1 mL TOPICAL SPRAY [Tetracyte Topical Tetracycline Hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline (2% alcoholic solution)
Trial: 30170579
Drug: BTI320 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BTI320 4 g (low dose)
Trial: 29071948
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) therapy, treated by EA stimulation of bilateral Neiting (ST 44), Fenglong (ST 40), Zusanli (ST 36), Huaroumen (ST 24), Tianshu (ST 25), Wailing (ST 26), Shuidao (ST 28), Fujie (SP 14), Daheng (SP 13) for 25 min, once every other day, 3 times per week for 3 months.
Trial: 29071948
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for weight reduction).
Trial: 21868752
Drug: 150 IU
RxNorm normalized name: Follitropin Beta 150 IU/0.5 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 IU recombinant human follicle‐stimulating hormone (rFSH) administered on alternate days for 90 days
Trial: 21868752
Drug: Nonantioxidant vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonantioxidant vitamin supplements
Trial: 21868752
Drug: rFSH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rFSH treatment in patients with high basal DFI values (>15%)
Trial: 21868752
Drug: Vitamin supplements
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin supplements in patients with high basal DFI values (>15%)
Trial: 17443649
Drug: nab-paclitaxel 70
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-paclitaxel 70 mg/m2
Trial: 17443649
Drug: nab-paclitaxel 100
RxNorm normalized name: paclitaxel 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nab-paclitaxel 100 mg/m2
Trial: 10233320
Drug: Intracutaneous injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracutaneous injections of botulinum A toxin (200 mouse units)
Trial: 7846789
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (placebo, 11 patients)
Trial: 19890266
Drug: d‐amphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐amphetamine (10 mg)
Trial: 27396241
Drug: linagliptin (5mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linagliptin (5mg, monotherapy or combination therapy)
Trial: 11451319
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoconazole daily for 3 months
Trial: 718514
Drug: GITS 15/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GITS 15/125 (15 mg/hr, administered twice a day)
Trial: 718514
Drug: Conventional 250‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional 250‐mg acetazolamide tablets
Trial: 28375887
Drug: Intraoperative soft‐tissue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative soft‐tissue infiltration of bupivacaine liposome injectable suspension
Trial: 26500462
Drug: High Protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Protein group (HP) consuming >3 g/kg/d of dietary protein
Trial: 17713332
Drug: Ozone treatment
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone treatment for 40 seconds
Trial: 17713332
Drug: Air treatment
RxNorm normalized name: GLYCERIN 3.88 mg in 1 mL TOPICAL SHAMPOO [HAIR TREATMENT PREMIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air treatment for 40 seconds (Control)
Trial: 15107371
Drug: Pethidine (PET)
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine (PET) 50 mg intramuscularly plus placebo intravenously
Trial: 15107371
Drug: Placebo (PLC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLC) intramuscular and intravenous
Trial: 12269647
Drug: MFNS 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFNS 200 microg, twice daily
Trial: 12269647
Drug: MFNS 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFNS 400 microg, twice daily
Trial: 9839094
Drug: Acarbose (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (25 mg t.i.d. to 100 mg t.i.d. over 24 weeks)
Trial: 2910779
Drug: Intravenous cis-platinum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cis-platinum injection
Trial: 19247240
Drug: Once-weekly dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly dressing change
Trial: 19247240
Drug: Twice-weekly dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly dressing change
Trial: 9784909
Drug: Chronic administration
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic administration of propionyl-L-carnitine (1.5 mg/d for 1 month)
Trial: 7908532
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg and 100 mg
Trial: 7908532
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg twice daily and 15 mg twice daily
Trial: 3198977
Drug: Tiapamil (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapamil (lower dose)
Trial: 3198977
Drug: Tiapamil (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapamil (higher dose)
Trial: 3198977
Drug: Nifedipine (lower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (lower dose)
Trial: 3198977
Drug: Nifedipine (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (higher dose)
Trial: 22655053
Drug: peginterferon-α2a 180
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: peginterferon-α2a 180 µg once weekly and ribavirin 800 mg daily
Trial: 18545197
Drug: L-carnitine L-tartrate
RxNorm normalized name: L-carnitine (free form) (as L-carnitine L-tartrate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine L-tartrate (LCLT) 2 g/d for 23 days
Trial: 12548090
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN, 30 mg TID)
Trial: 12548090
Drug: Pentaerythrityl tetranitrate
RxNorm normalized name: pentaerythrityl tetraethylhexanoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaerythrityl tetranitrate (PETN, 80 mg TID)
Trial: 10526912
Drug: Intensified antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified antihypertensive therapy (IT group)
Trial: 10526912
Drug: Routine antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine antihypertensive therapy (RT group)
Trial: 7574765
Drug: Intra-arterial (IA)
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial (IA) chemotherapy
Trial: 29221491
Drug: Gantenerumab 225
RxNorm normalized name: Gantenerumab
DrugBank: Gantenerumab (DB12034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gantenerumab 225 mg
Trial: 20546699
Drug: Cognitive-Behavioral Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Treatment (CBT) for BZ Discontinuation
Trial: 20546699
Drug: Taper plus
RxNorm normalized name: DRESSING,RESTORE PLUS TAPERED H#519959
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taper plus relaxation
Trial: 16308444
Drug: Wobenzym (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wobenzym (1 tablet for 6 kg weight, administered for 3 months)
Trial: 10227638
Drug: Oral high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral high-dose methylprednisolone
Trial: 8457123
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (0.5 g twice a day for 5 days)
Trial: 19714275
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment with sling for comfort
Trial: 15008768
Drug: Incremental infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Incremental infusion of oxytocin maintained after 5 cm dilation (Group A)
Trial: 8711499
Drug: Treatment continuation
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment continuation (Epirubicin/Ifosfamide)
Trial: 8711499
Drug: Treatment interruption
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment interruption (control)
Trial: 30415601
Drug: Sacubitril‐valsartan (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sacubitril‐valsartan (target dose, 97 mg of sacubitril with 103 mg of valsartan twice daily)
Trial: 22287674
Drug: Nitrate diet
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate diet (22 g nitrate/kg DM)
Trial: 8375267
Drug: Human NPH
RxNorm normalized name: INSULIN HUMAN NPH 100 UNIT/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human NPH insulin
Trial: 9521197
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with acyclovir and/or ganciclovir
Trial: 1870247
Drug: Intensive dietetic-hygienic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive dietetic-hygienic measures and hypolipidemic (mainly clofibrate and/or probucol) and antihypertensive (mainly beta-blockers and/or diuretics) drugs
Trial: 27807291
Drug: Extracorporeal Shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Shockwave Therapy (ESWT)
Trial: 12413620
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 800 microg
Trial: 9848486
Drug: HVB bisacodyl
RxNorm normalized name: Bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HVB bisacodyl suppositories
Trial: 9848486
Drug: PGB bisacodyl
RxNorm normalized name: Bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGB bisacodyl suppositories
Trial: 23135343
Drug: Colobreathe dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colobreathe dry powder for inhalation (CDPI, one capsule containing colistimethate sodium 1,662,500 IU, twice daily)
Trial: 23135343
Drug: Tobramycin inhaler
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin inhaler solution (TIS, 300 mg/5 ml, twice daily for three 28-day cycles)
Trial: 23135343
Drug: Colobreathe dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colobreathe dry powder for inhalation (CDPI)
Trial: 23135343
Drug: Tobramycin inhaler
RxNorm normalized name: tobramycin Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin inhaler solution (TIS)
Trial: 16480401
Drug: CDP571 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP571 (10 mg/kg, intravenous, 8-weekly through to week 32)
Trial: 10855459
Drug: Cyclandelate 800
RxNorm normalized name: Cyclandelate
DrugBank: Cyclandelate (DB04838)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclandelate 800 mg bid
Trial: 9116778
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (900-1200 mg/day)
Trial: 29528704
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (Cholecalciferol) 50,000 IU in tablet form, monthly, for 1 yr
Trial: 29528704
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 400 IU in tablet form, monthly, for 1 yr
Trial: 24407182
Drug: Tadalafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (20 mg every other day)
Trial: 20604918
Drug: A-Part Gel
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-Part Gel
Trial: 16116007
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 3 mg
Trial: 12183495
Drug: 6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/kg caffeine 1 h preexercise (Precaf)
Trial: 12183495
Drug: 6 x
RxNorm normalized name: Mepilex AG 6 x 6"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 x 1 mg/kg caffeine every 20 min throughout steady-state (Durcaf)
Trial: 12183495
Drug: 2 x
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 x 5 ml/kg Coca-Cola during steady-state and TT (Coke)
Trial: 28228425
Drug: Prebiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic supplementation (8 g oligofructose-enriched inulin/d)
Trial: 29041979
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) treatment
Trial: 24166792
Drug: Other one-carbon
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other one-carbon metabolism biomarkers
Trial: 22060248
Drug: Unguided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unguided self-help (10-week web-based treatment without therapist support)
Trial: 19082528
Drug: Monotherapy (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (calcium supplement)
Trial: 18251131
Drug: Terlipressin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (1 mg every four hours for 48 hours)
Trial: 18251131
Drug: Albumin (8g/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin (8g/L of removed ascites)
Trial: 14679443
Drug: Ampicillin-sulbactam/amoxicillin-clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam/amoxicillin-clavulanate
Trial: 14679443
Drug: Linezolid and
RxNorm normalized name: Linezolid
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid and comparators (oral and intravenous formulations)
Trial: 2692971
Drug: Fenticonazole (2%)
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenticonazole (2%) spray
Trial: 20561625
Drug: 45 g
RxNorm normalized name: SODIUM CHLORIDE 0.045 g in 5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 g whey protein isolate
Trial: 20561625
Drug: 45 g
RxNorm normalized name: SODIUM CHLORIDE 0.045 g in 5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 g sodium caseinate
Trial: 15830219
Drug: 0.65 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.65 g/kg alcohol
Trial: 15571441
Drug: 0.0 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0 g/kg (placebo)
Trial: 15332386
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate (SFC) combination (50/500 microg)
Trial: 11164668
Drug: Topical silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical silver sulfadiazine combined with cerium nitrate (SSD‐CN)
Trial: 24121806
Drug: Topical silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical silver sulfadiazine (SSD)
Trial: 8492964
Drug: Droxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droxicam (20 mg/day, orally administered)
Trial: 30143316
Drug: Ultrasound-guided femoral
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided femoral nerve block with up to 20mL of 0.3mL.kg‐1 of 0.5% bupivacaine and intravenous tramadol
Trial: 30143316
Drug: Standard management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard management group; up to 3mL of 0.9% saline in the femoral sheath and intravenous tramadol
Trial: 20593142
Drug: Magnesium (Mg)
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (Mg) supplementation during CABG surgery
Trial: 20593142
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Mg supplementation)
Trial: 20593142
Drug: NAC untreated
RxNorm normalized name: NAC
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NAC untreated group (placebo with dextrose solution)
Trial: 18703812
Drug: Warfarin (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (in SPORTIF V)
Trial: 18703812
Drug: Warfarin (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (in SPORTIF III)
Trial: 6734709
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no oral contraceptive steroids)